Rapid and sensitive method for determination of cyclophosphamide in patients plasma samples utilizing microextraction by packed sorbent online with liquid chromatography-tandem mass spectrometry (MEPS-LC-MS/MS)

Journal of Liquid Chromatography and Related Technologies

Volumn 31, Issue 5, 2008, Pages 683-694

  Said, Rana ^a,b   Hassan, Zuzan ^a,b   Hassan, Moustapha ^a,b   Abdel Rehim, Mohamed ^c,d  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

^d KARLSTAD UNIVERSITY   (Sweden)

Author keywords

Cyclophosphamide; LC MS MS; LC UV; Microextraction in Packed Syringe; Plasma; Sample Preparation

Indexed keywords

AMIDES; CORRELATION METHODS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PATIENT MONITORING;

CYCLOPHOSPHAMIDE; MICROEXTRACTION; TANDEM MASS SPECTROMETRY;

PLASMA (HUMAN);

CYCLOPHOSPHAMIDE; SORBENT;

ACCURACY; ARTICLE; CALIBRATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; GAS CHROMATOGRAPHY; HUMAN; INTERMETHOD COMPARISON; LIQUID CHROMATOGRAPHY; LIQUID PHASE MICROEXTRACTION; QUALITY CONTROL; TANDEM MASS SPECTROMETRY; ULTRAVIOLET RADIATION;

EID: 38649085601     PISSN: 10826076     EISSN: 1520572X     Source Type: Journal    
DOI: 10.1080/10826070701853867     Document Type: Article

References (18)

1. Moore, M.J. Clinical pharmacokinetics of cyclophosphamide. Clin. Pharmacokinet. 1991, 20, 194-208.
2. Binotto, G.; Trentin, L.; Semenzato, G. Ifosfamide and cyclophosphamide: effects on immunosurveillance. Oncology 2003, 65, 17-20.
3. Brock, N. Oxazaphosphorine cytostatics: past-present-future. Seventh Cain Memorial Award lecture. Cancer Res 1989, 49, 1-7.
4. Clarke, L.; Waxman., D.J. Oxidative metabolism of cyclophosphamide: identification of the hepatic monooxygenase catalysts of drug activation. Cancer Res 1989, 49, 2344-2350.
5. Hassan, M.; Nilsson, C.; Olsson, H.; Lundin, J.; Osterborg, A. The influence of interferon-alpha on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite in patients with multiple myeloma. Eur. J. Haematol. 1999, 63, 163-170.
6. Hassan, M.; Ljungman, P.; Ringden, O.; Hassan, Z.; Oberg, G.; Nilsson, C.; Bekassy, A.; Bielenstein, M.; Abdel-Rehim, M.; Georen, S.; Astner, L. The effect of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite: time interval influence on therapeutic efficacy and therapy-related toxicity. Bone Marrow Transplant. 2000, 25, 915-924.
7. Slattery, J.T.; Kalhorn, T.F.; McDonald, G.B.; Lambert, K.; Buckner, C.D.; Bensinger, W.I.; Anasetti, C.; Appelbaum, F.R. Conditioning regimen-dependent disposition of cyclophosphamide and hydroxycyclophosphamide in human marrow transplantation patients. J. Clin. Oncol. 1999, 14, 1484-1494.
8. Silvertand, L.H.H.; Vazvaei, F.; Weigl, P.; Rosing, H.; Hillebrand, M.J.X.; van Maanen, M.J.; Beijnen, J.H. Simultaneous quantification of fludarabine and cyclophosphamide in human plasma by high performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry. Rapid Commun. Mass Spectrum 2005, 19, 3673-3680.
9. Sadagopan, N.; Cohen, L.; Roberts, B.; Collard, W.; Omer, C. Liquid chromatography-tandem mass spectrometric quantitation of cyclophosphamide and its hydroxy metabolite in plasma and tissue for determination of tissue distribution. J. Chromatogr. B 2001, 759, 277-284.
10. Ellen, S.; Hilde, R.; Jos, H. Liquid chromatography-mass spectrometry for the quantitation bioanalysis of anticancer drugs. Mass Spectrom. Rev. 2005, 24, 887-917.
11. De Jonge, M.E.; Van Dam, S.M.; Hillebrand, M.J.X.; Rosing, H.; Huitema, A.D.R.; Rodenhuis, S.; Beijnen, J.H. Simultaneous quantification of cyclophosphamide, 4-hydroxycyclophosphamide, N,N,N-triethylenethiophosphoramide(thiotepa) and N,N,N-triethylenephosphoramide (tepa) in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry. J. Mass Spectrum 2004, 39, 262-271.
12. Baumann, F.; Lorenz, C.; Jaehde, U.; Preiss, R. Determination of cyclophosphamide and its metabolites in human plasma by high-performance liquid chromatography-mass spectrometry. J. Chromatogr. B 1999, 729, 297-305.
13. Barbieri, A.; Sabatini, L.; Indiveri, P.; Bonfiglioli, R.; Lodi, V.; Violante, F.S. Simultaneous determination of low levels of methotrexate and cyclophosphamide in human urine by micro liquid chromatography/electrospray ionization tandem mass spectrometry Rapid Commun. Mass Spectrom. 2006, 20, 1889-1893.
14. Baumann, F.; Preiss, R. Cyclophosphamide and related anticancer drugs. J. Chromatogr. B 2001, 764, 173-192.
15. El-Beqqali, A.; Kussak, A.; Abdel-Rehim, M. Microextraction in packed syringe/ liquid chromatography/electrospray tandem mass spectrometry for quantification of acebutolol and metoprolol in human plasma and urine samples. J. Liq. Chromatogr. & Rel. Technol. 2007, 30 (4), 575-586.
16. Abdel-Rehim, M.; Askemark, Y.; Norsten-Höög, C.; Petterson, K.J.; Halldin, M. Quantification of 4-OH-2, 6-xylidine and its conjugate in human urine samples utilising microextraction in packed syringe online with liquid chromatography and electrospray tandem mass spectrometry (MEPS-LC-MS/MS). J. Liq. Chromatogr. & Rel. Technol. 2006, 29 (16), 2413-2424.
17. Abdel-Rehim, M.; Altun, Z.; Jagerdeo, E.; Blomberg, L. Drug screening using microextraction in packed syringe (MEPS)/LC-MS utilizing monolithic-based sorbent materia. J. Liq. Chromatogr. & Rel. Technol. 2006, 29 (6), 829-839.
18. Abdel-Rehim, M.; Dahlgren, M.; Blomberg, L. Quantification of ropivacaine and its major metabolites in human urine samples utilizing microextraction in packed syringe online with liquid chromatography-tandem mass spectrometry (MEPS-LC-MS-MS). J. Sep. Sci. 2006, 29 (11), 1658-1661.